Intravenous itraconazole followed by oral itraconazole in the treatment of invasive pulmonary aspergillosis in patients with hematologic malignancies, chronic granulomatous disease, or AIDS

Clinical infectious diseases: an official publication of the Infectious Diseases Society of America

Volumn 33, Issue 8, 2001, Pages e83-90

  Caillot, D ^a   Bassaris, H ^b   Mc Geer, A ^c   Arthur, C ^d   Prentice, H G ^e   Seifert, W ^f   De Beule, K ^f  

^a DIJON UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^c PRINCESS MARGARET HOSPITAL   (Canada)

^d ROYAL NORTH SHORE HOSPITAL   (Australia)

^e ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^f JANSSEN RESEARCH FOUNDATION   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ITRACONAZOLE;

ADULT; AGED; AIDS RELATED COMPLEX; ARTICLE; ASPERGILLOSIS; BLOOD DISEASE; CHRONIC GRANULOMATOUS DISEASE; CLINICAL TRIAL; FEMALE; HUMAN; IMMUNE DEFICIENCY; INTRAVENOUS DRUG ADMINISTRATION; LUNG MYCOSIS; MALE; MICROBIOLOGY; MIDDLE AGED; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; ASPERGILLOSIS; FEMALE; GRANULOMATOUS DISEASE, CHRONIC; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOCOMPROMISED HOST; INJECTIONS, INTRAVENOUS; ITRACONAZOLE; LUNG DISEASES, FUNGAL; MALE; MIDDLE AGED;

EID: 0010589469     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/323020     Document Type: Article

References (0)